Kazutake Tsujikawa

7.1k total citations · 1 hit paper
145 papers, 5.3k citations indexed

About

Kazutake Tsujikawa is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kazutake Tsujikawa has authored 145 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Molecular Biology, 23 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Kazutake Tsujikawa's work include RNA modifications and cancer (23 papers), Muscle Physiology and Disorders (18 papers) and Cancer-related molecular mechanisms research (13 papers). Kazutake Tsujikawa is often cited by papers focused on RNA modifications and cancer (23 papers), Muscle Physiology and Disorders (18 papers) and Cancer-related molecular mechanisms research (13 papers). Kazutake Tsujikawa collaborates with scholars based in Japan, United States and Germany. Kazutake Tsujikawa's co-authors include Hiroshi Yamamoto, So‐ichiro Fukada, Shin’ichi Takeda, Yuko Miyagoe‐Suzuki, Akiyoshi Uezumi, Yuko Ueda, Keiji Shimada, Kentaro Jingushi, Kaori Kitae and Noboru Konishi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Immunity.

In The Last Decade

Kazutake Tsujikawa

143 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle

2011 499 citations Akiyoshi Uezumi, Tomohiro Yoneda et al. profile →

Peers

Countries citing papers authored by Kazutake Tsujikawa

Since Specialization

Citations

This map shows the geographic impact of Kazutake Tsujikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazutake Tsujikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazutake Tsujikawa more than expected).

Fields of papers citing papers by Kazutake Tsujikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazutake Tsujikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazutake Tsujikawa. The network helps show where Kazutake Tsujikawa may publish in the future.

Co-authorship network of co-authors of Kazutake Tsujikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kazutake Tsujikawa. A scholar is included among the top collaborators of Kazutake Tsujikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazutake Tsujikawa. Kazutake Tsujikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Small extracellular vesicles carrying reovirus, tumor antigens, interferon-β, and damage-associated molecular patterns for efficient tumor treatment 2024 ·Journal of Controlled Release ·(unknown), Chieko Inoue, (unknown), Kentaro Jingushi, (unknown), Shigeru Kawakami, Kazutake Tsujikawa, Masashi Tachibana, Hiroyuki Mizuguchi, Fuminori Sakurai	8
2	RAMP1 Signaling Mitigates Acute Lung Injury by Distinctively Regulating Alveolar and Monocyte-Derived Macrophages 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), Kazutake Tsujikawa, Hirotsugu Okamoto, (unknown)	4
3	RNA-modifying enzyme Alkbh8 is involved in mouse embryonic development 2024 ·iScience ·M. Nakai, Hiroaki Hase, Yutong Zhao, Katsuya Okawa, (unknown), (unknown), Kaori Kitae, Kazutake Tsujikawa	2
4	Hypoxia regulates tumour characteristic RNA modifications in ovarian cancers 2022 ·FEBS Journal ·(unknown), Shunsuke Miyamoto, Kentaro Jingushi, (unknown), Tomohito Tanaka, Kohei Taniguchi, Kazumasa Komura, Masahide Ohmichi, Kazutake Tsujikawa	7
5	Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients 2022 ·Cancer Immunology Immunotherapy ·Kentaro Jingushi, Atsunari Kawashima, Takuro Saito, Takayuki Kanazawa, Daisuke Motooka, Tomonori Kimura, Masashi Mita, Akinaru Yamamoto, Toshihiro Uemura, Gaku Yamamichi, Koichi Okada, Eisuke Tomiyama, Yoko Koh, Makoto Matsushita, Taigo Kato, Koji Hatano, Motohide Uemura, Kazutake Tsujikawa, Hisashi Wada, Norio Nonomura	10
6	Azurocidin is loaded into small extracellular vesicles via its N‐linked glycosylation and promotes intravasation of renal cell carcinoma cells 2021 ·FEBS Letters ·(unknown), Kentaro Jingushi, Koji Ueda, Kazutake Tsujikawa	7
7	Cell-autonomous and redundant roles of Hey1 and HeyL in muscle stem cells: HeyL requires Hes1 to bind diverse DNA sites 2019 ·Development ·(unknown), Miki Nakamura, Nobumasa Hino, Jumpei Nogami, (unknown), Takahiko Sato, Lidan Zhang, Kazutake Tsujikawa, Toru Tanaka, (unknown), Yoshiaki Okada, Takefumi Doi, Hiroki Kokubo, Akihito Harada, Akiyoshi Uezumi, Manfred Gessler, Yasuyuki Ohkawa, So‐ichiro Fukada	38
8	Muscle regeneration is disrupted by cancer cachexia without loss of muscle stem cell potential 2018 ·PLoS ONE ·(unknown), Atsushi Hinohara, Masashi Tachibana, Kazutake Tsujikawa, So‐ichiro Fukada	38
9	The expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinoma 2017 ·Toshiro Kinouchi, Motohide Uemura, Takuji Hayashi, Kyosuke Matsuzaki, Norihiko Kawamura, Atsunari Kawashima, (unknown), Akira Nagahara, Kazutoshi Fujita, Kentaro Jingushi, (unknown), Kazutake Tsujikawa, Norio Nonomura	2
10	ALKBH8 promotes bladder cancer growth and progression through regulating the expression of survivin 2016 ·Biochemical and Biophysical Research Communications ·(unknown), Ryoji Kawakami, (unknown), Kazuhiro Nakajima, Kaori Kitae, (unknown), (unknown), Hiroaki Hase, Yuko Ueda, Kentaro Jingushi, Kazutake Tsujikawa	31
11	Evidence of Notch-Hesr-Nrf2 Axis in Muscle Stem Cells, but Absence of Nrf2 Has No Effect on Their Quiescent and Undifferentiated State 2015 ·PLoS ONE ·Masahiko Yamaguchi, Satoshi Murakami, Tomohiro Yoneda, Miki Nakamura, Lidan Zhang, Akiyoshi Uezumi, Sumiaki Fukuda, Hiroki Kokubo, Kazutake Tsujikawa, So‐ichiro Fukada	14
12	miR-629 Targets TRIM33 to Promote TGFβ/Smad Signaling and Metastatic Phenotypes in ccRCC 2014 ·Molecular Cancer Research ·Kentaro Jingushi, Yuko Ueda, Kaori Kitae, Hiroaki Hase, Hiroshi Egawa, (unknown), Ryoji Kawakami, (unknown), (unknown), T Kobayashi, Wataru Nakata, Kazutoshi Fujita, Motohide Uemura, Norio Nonomura, Kazutake Tsujikawa	67
13	Expression of ABCB6 is related to resistance to 5-FU, SN-38 and vincristine. 2014 ·PubMed ·Kentaro Minami, (unknown), (unknown), Sho Tabata, (unknown), Masatatsu Yamamoto, (unknown), Yoshinari Shinsato, Tokushi Tachiwada, Zhe‐Sheng Chen, Kazutake Tsujikawa, Masayuki Nakagawa, Naohiko Seki, Shin‐ichi Akiyama, Kazunari Arima, Yasuo Takeda, Tatsuhiko Furukawa	24
14	ALKBH3 Contributes to Survival and Angiogenesis of Human Urothelial Carcinoma Cells through NADPH Oxidase and Tweak/Fn14/VEGF Signals 2012 ·Clinical Cancer Research ·Keiji Shimada, Tomomi Fujii, Kazutake Tsujikawa, Satoshi Anai, Kiyohide Fujimoto, Noboru Konishi	69
15	A Novel Human AlkB Homologue, ALKBH8, Contributes to Human Bladder Cancer Progression 2009 ·Cancer Research ·Keiji Shimada, Mitsutoshi Nakamura, Satoshi Anai, Marco A. De Velasco, Motoyoshi Tanaka, Kazutake Tsujikawa, Yukiteru Ouji, Noboru Konishi	133
16	Copper-Transporting P-Type ATPase, ATP7A, Confers Multidrug Resistance and Its Expression Is Related to Resistance to SN-38 in Clinical Colon Cancer 2007 ·Cancer Research ·(unknown), (unknown), Masaharu Komatsu, Ryuji Ikeda, Stephen Firth, Xiaofang Che, Masatatsu Yamamoto, Kazutake Tsujikawa, Masaki Kitazono, Takashi Ishizawa, Tōru Takeuchi, Takashi Aikou, Julian F. B. Mercer, Shin‐ichi Akiyama, Tatsuhiko Furukawa	53
17	Role of γδT Cells in the Inflammatory Response of Experimental Colitis Mice 2003 ·The Journal of Immunology ·Takahiro Tsuchiya, Sumiaki Fukuda, Hiromasa Hamada, Akihiro Nakamura, Yasuhiro Kohama, Hiromichi Ishikawa, Kazutake Tsujikawa, Hiroshi Yamamoto	102
18	Distinct Functions of the Two Protein Tyrosine Phosphatase Domains of LAR (Leukocyte Common Antigen-Related) on Tyrosine Dephosphorylation of Insulin Receptor 2001 ·Molecular Endocrinology ·Kazutake Tsujikawa, Naoto Kawakami, (unknown), (unknown), Tatsuhiko Furukawa, Haruo Saito, Hiroshi Yamamoto	32
19	Molecular cloning and characterization of a novel human STE20-like kinase, hSLK 2000 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·(unknown), Kazutake Tsujikawa, Susumu Itoh, (unknown), Yasuhiro Kohama, Hiroshi Yamamoto	27
20	Molecular cloning of 25-hydroxyvitamin D-3 24-hydroxylase (Cyp-24) from mouse kidney: its inducibility by vitamin D-3 1995 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Susumu Itoh, Takuya Yoshimura, (unknown), (unknown), Kazutake Tsujikawa, Yasuhiro Kohama, TSUTOMU MIMURA	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact